Cargando…
Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure
It has now been almost 20 years since first clinical trials of stem cell therapy for heart repair were initiated. While initial preclinical data were promising and suggested that stem cells may be able to directly restore a diseased myocardium, this was never unequivocally confirmed in the clinical...
Autores principales: | Banovic, Marko, Poglajen, Gregor, Vrtovec, Bojan, Ristic, Arsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783726/ https://www.ncbi.nlm.nih.gov/pubmed/36547426 http://dx.doi.org/10.3390/jcdd9120429 |
Ejemplares similares
-
Cell Therapy in Heart Failure with Preserved Ejection Fraction
por: Frljak, Sabina, et al.
Publicado: (2022) -
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019) -
A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction
por: Vrtovec, Bojan, et al.
Publicado: (2022) -
Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019) -
Endpoints in stem cell trials in ischemic heart failure
por: Banovic, Marko, et al.
Publicado: (2015)